AngioDynamics, Inc. (ANGO)
- Previous Close
6.26 - Open
6.29 - Bid 6.00 x 100
- Ask 6.06 x 100
- Day's Range
6.00 - 6.30 - 52 Week Range
5.26 - 11.38 - Volume
378,096 - Avg. Volume
523,572 - Market Cap (intraday)
241.529M - Beta (5Y Monthly) 0.68
- PE Ratio (TTM)
-- - EPS (TTM)
-4.80 - Earnings Date Jul 10, 2024 - Jul 15, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
13.50
AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
www.angiodynamics.comRecent News: ANGO
Performance Overview: ANGO
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ANGO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ANGO
Valuation Measures
Market Cap
250.94M
Enterprise Value
198.08M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.77
Price/Book (mrq)
1.15
Enterprise Value/Revenue
0.61
Enterprise Value/EBITDA
-5.65
Financial Highlights
Profitability and Income Statement
Profit Margin
-59.37%
Return on Assets (ttm)
-4.81%
Return on Equity (ttm)
-62.42%
Revenue (ttm)
324.01M
Net Income Avi to Common (ttm)
-192.37M
Diluted EPS (ttm)
-4.80
Balance Sheet and Cash Flow
Total Cash (mrq)
78.45M
Total Debt/Equity (mrq)
1.81%
Levered Free Cash Flow (ttm)
33.29M
Research Analysis: ANGO
Company Insights: ANGO
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: ANGO
Daily – Vickers Top Buyers & Sellers for 04/09/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
ANGO: Lowering target price to $8.00
ANGIODYNAMICS INC has an Investment Rating of HOLD; a target price of $8.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetANGO: What does Argus have to say about ANGO?
ANGIODYNAMICS INC has an Investment Rating of HOLD; a target price of $9.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetANGO: Lowering target price to $9.00
ANGIODYNAMICS INC has an Investment Rating of HOLD; a target price of $9.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice Target